Corcept Therapeutics
CORT
CORT
189 hedge funds and large institutions have $1.43B invested in Corcept Therapeutics in 2017 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 65 increasing their positions, 46 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% more funds holding
Funds holding: 156 → 189 (+33)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
3.67% more ownership
Funds ownership: 61.7% → 65.37% (+3.7%)
Holders
189
Holding in Top 10
6
Calls
$11.7M
Puts
$4.89M
Top Buyers
| 1 | +$34.7M | |
| 2 | +$19M | |
| 3 | +$12M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$11.5M |
| 5 |
AAM
AMI Asset Management
Los Angeles,
California
|
+$10.2M |
Top Sellers
| 1 | -$43M | |
| 2 | -$37.1M | |
| 3 | -$13.2M | |
| 4 |
ISL
Ingalls & Snyder LLC
New York
|
-$8.37M |
| 5 |
Morgan Stanley
New York
|
-$8.12M |